# Lacticaseibacillus Rhamnosus CA15 (DSM 33960) Strain as a New Driver in Restoring the Normal Vaginal Microbiota

> **NCT05796921** · NA · COMPLETED · sponsor: **Agnese Maria Chiara Rapisarda** · enrollment: 200 (actual)

## Conditions studied

- Bacterial Vaginosis
- Candidosis Vaginal
- Urinary Tract Infections

## Interventions

- **DIETARY_SUPPLEMENT:** Lacticaseibacillus rhamnosus CA15 (DSM 33960) probiotic strain
- **DIETARY_SUPPLEMENT:** placebo

## Key facts

- **NCT ID:** NCT05796921
- **Lead sponsor:** Agnese Maria Chiara Rapisarda
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-04-10
- **Primary completion:** 2024-06-29
- **Final completion:** 2025-05-06
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2025-07-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05796921

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05796921, "Lacticaseibacillus Rhamnosus CA15 (DSM 33960) Strain as a New Driver in Restoring the Normal Vaginal Microbiota". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT05796921. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*